Glaukos reported positive topline Phase 4 data for iDose TR used during cataract surgery in open-angle glaucoma and ocular ...

A large BJO study links statin use to lower open-angle glaucoma risk and fewer surgeries or eye drops. Learn the data, limits ...

SpyGlass Pharma has reported 4-year interim results from the first-in-human (FIH) trial of its Bimatoprost Drug Pad-IOL System (BIM-IOL System), extending what the company describes as the “longest ...

Although no significant results were found overall, a subgroup analysis showed that patients between 70 and 74 years of age ...

The US-based eye-care company is also developing intraocular lens products, while low adoption of premium cataract procedures ...

In the latest episode of The Retina TL;DR with Dr. Weng—Part 2 of a special two-part series—host Christina Y. Weng, MD, MBA, ...

Meter, IQ-SurgiView and IQ-Flow demonstrated live for the first time; surgeons single out robotic visualization, console-free ECP and a compact all-in-one diagnostic suited to office-based surgery ...

Epigenetic reprogramming is rewriting what we thought we knew about permanent vision loss.

Ophthalmologist J. Hunter Aultman, MD, plans to open an eye practice in Vicksburg, Miss., before year-end, the Vicksburg Post reported. The practice will operate in a building now under renovation. Dr ...

About Sight Sciences Sight Sciences is an eyecare technology company focused on developing and commercializing innovative and interventional solutions intended to transform care and improve patients’ ...

Dr. J. Hunter Aultman will bring eye care services, including cataract surgery and treatment for eye diseases, to a renovated ...

A 25-year-old Black man presented to the Tufts Medical Center emergency department with blurred vision in both eyes.The ...